{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T21:10:24Z","timestamp":1793481024655,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"52","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.vaccine.2013.10.034","type":"journal-article","created":{"date-parts":[[2013,10,31]],"date-time":"2013-10-31T00:49:46Z","timestamp":1383180586000},"page":"6225-6231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["DNA immunization with eukaryotic initiation factor-2\u03b1 of Toxoplasma gondii induces protective immunity against acute and chronic toxoplasmosis in mice"],"prefix":"10.1016","volume":"31","author":[{"given":"Jia","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Yang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Hui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eskild","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Qun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-Quan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.10.034_bib0005","series-title":"Toxoplasmosis of animals and humans","first-page":"13","volume":"1\u20133","author":"Dubey","year":"2010"},{"key":"10.1016\/j.vaccine.2013.10.034_bib0010","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1128\/CMR.05013-11","article-title":"Epidemiology of and diagnostic strategies for toxoplasmosis","volume":"25","author":"Robert-Gangneux","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2013.10.034_bib0015","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1756-3305-5-152","article-title":"Canine and feline parasitic zoonoses in China","volume":"5","author":"Chen","year":"2012","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.vaccine.2013.10.034_bib0020","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/1756-3305-6-168","article-title":"Seroprevalence of Toxoplasma gondii in horses and donkeys in Yunnan Province. Southwestern China","volume":"6","author":"Miao","year":"2013","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.vaccine.2013.10.034_bib0025","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","article-title":"Toxoplasmosis","volume":"363","author":"Montoya","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2013.10.034_bib0030","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.ijpara.2009.02.004","article-title":"Toxoplasmosis: a history of clinical observations","volume":"39","author":"Weiss","year":"2009","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.vaccine.2013.10.034_bib0035","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.2217\/fmb.09.89","article-title":"Toxoplasma gondii infection and cerebral toxoplasmosis in HIV-infected patients","volume":"4","author":"Pereira-Chioccola","year":"2009","journal-title":"Future Microbiol"},{"key":"10.1016\/j.vaccine.2013.10.034_bib0040","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1089\/fpd.2010.0795","article-title":"Toxoplasma in animals, food, and humans: an old parasite of new concern","volume":"8","author":"Cenci-Goga","year":"2011","journal-title":"Foodborne Pathog Dis"},{"key":"10.1016\/j.vaccine.2013.10.034_bib0045","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1086\/427660","article-title":"A combination of antigenic regions of Toxoplasma gondii microneme proteins induces protective immunity against oral infection with parasite cysts","volume":"191","author":"Beghetto","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.10.034_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vetpar.2009.02.026","article-title":"Toxoplasmosis in sheep \u2013 the last 20 years","volume":"163","author":"Dubey","year":"2009","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2013.10.034_bib0055","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.ijpara.2008.06.002","article-title":"Control of the risk of human toxoplasmosis transmitted by meat","volume":"38","author":"Kijlstra","year":"2008","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.vaccine.2013.10.034_bib0060","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1586\/erv.10.113","article-title":"Vaccination against Toxoplasma gondii: an increasing priority for collaborative research?","volume":"9","author":"Innes","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2013.10.034_bib0065","doi-asserted-by":"crossref","first-page":"5631","DOI":"10.1016\/j.vaccine.2012.06.081","article-title":"Enhancement of protective immune responses induced by Toxoplasma gondii dense granule antigen 7 (GRA7) against toxoplamosis in mice using a prime-boost vaccination strategy","volume":"30","author":"Min","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.10.034_bib0070","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1016\/j.vaccine.2013.05.040","article-title":"Evaluation of protective effect of pVAX-TgMIC13 plasmid against acute and chronic Toxoplasma gondii infection in a murine model","volume":"31","author":"Yuan","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.10.034_bib0075","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1128\/CVI.00397-12","article-title":"Protective efficacy of a Toxoplasma gondii rhoptry protein 13 plasmid DNA vaccine in mice","volume":"19","author":"Wang","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2013.10.034_bib0080","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1128\/CVI.00312-10","article-title":"Protective immunity induced by Toxoplasma gondii rhoptry protein 16 against toxoplasmosis in mice","volume":"18","author":"Yuan","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2013.10.034_bib0085","doi-asserted-by":"crossref","first-page":"6614","DOI":"10.1016\/j.vaccine.2011.06.110","article-title":"Protective effect against toxoplasmosis in mice induced by DNA immunization with gene encoding Toxoplasma gondii ROP18","volume":"29","author":"Yuan","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.10.034_bib0090","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.exppara.2011.02.005","article-title":"Toxoplasma gondii: protective immunity against experimental toxoplasmosis induced by a DNA vaccine encoding the perforin-like protein 1","volume":"128","author":"Yan","year":"2011","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.vaccine.2013.10.034_bib0095","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1016\/j.vaccine.2012.01.073","article-title":"Toxoplasma gondii immune mapped protein-1(TgIMP1) is a novel vaccine candidate against toxoplasmosis","volume":"30","author":"Cui","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.10.034_bib0100","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1016\/j.vaccine.2011.01.089","article-title":"Induction of protective Th1 immune responses in mice by vaccination with recombinant Toxoplasma gondii nucleoside triphosphate hydrolase-II","volume":"29","author":"Tan","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.10.034_bib0105","doi-asserted-by":"crossref","first-page":"8838","DOI":"10.1016\/j.vaccine.2011.09.099","article-title":"Immunological responses induced by a DNA vaccine expressing RON4 and by immunogenic recombinant protein RON4 failed to protect mice against chronic toxoplasmosis","volume":"29","author":"Rashid","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.10.034_bib0110","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/j.vaccine.2013.01.027","article-title":"Protective immunity induced by a DNA vaccine expressing eIF4A of Toxoplasma gondii against acute toxoplasmosis in mice","volume":"31","author":"Chen","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.10.034_bib0115","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1042\/bj20040262","article-title":"Parasite-specific eIF2 (eukaryotic initiation factor-2) kinase required for stress-induced translation control","volume":"380","author":"Sullivan","year":"2004","journal-title":"Biochem J"},{"key":"10.1016\/j.vaccine.2013.10.034_bib0120","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1073\/pnas.1007610107","article-title":"Phosphorylation of eukaryotic initiation factor-2{alpha} promotes the extracellular survival of obligate intracellular parasite Toxoplasmagondii","volume":"107","author":"Joyce","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2013.10.034_bib0125","first-page":"684","article-title":"Vaccination with a DNA vaccine coding for perforin-like protein 1 and MIC6 induces significant protective immunity against Toxoplasma gondii","volume":"19","author":"Yan","year":"2012","journal-title":"ClinVaccine Immunol"},{"key":"10.1016\/j.vaccine.2013.10.034_bib0130","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.2307\/1591566","article-title":"Comparison of MTT colorimetric assay and tritiated thymidine uptake for lymphocyte proliferation assays using chicken splenocytes","volume":"36","author":"Bounous","year":"1992","journal-title":"Avian Dis"},{"key":"10.1016\/j.vaccine.2013.10.034_bib0135","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1146\/annurev.immunol.18.1.927","article-title":"DNA vaccines: immunology, application and optimization","volume":"18","author":"Gurunathan","year":"2000","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2013.10.034_bib0140","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1586\/erv.09.27","article-title":"Current status of toxoplasmosis vaccine development","volume":"8","author":"Kur","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2013.10.034_bib0145","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1586\/14760584.8.2.215","article-title":"Vaccination concepts against Toxoplasma gondii","volume":"8","author":"Garcia","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2013.10.034_bib0150","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00281-012-0339-3","article-title":"Immune response and immunopathology during toxoplasmosis","volume":"34","author":"Dupont","year":"2012","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.vaccine.2013.10.034_bib0155","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1600-065X.2010.00992.x","article-title":"Immunology of Toxoplasma gondii","volume":"240","author":"Munoz","year":"2011","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2013.10.034_bib0160","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1016\/j.vaccine.2010.01.031","article-title":"Functional characterization of in vivo effector CD4(+) and CD8(+) T cell responses in acute Toxoplasmosis: an interplay of IFN-gamma and cytolytic T cells","volume":"28","author":"Jongert","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.10.034_bib0165","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1128\/IAI.70.2.434-443.2002","article-title":"CD8(+)-T-cell immunity against Toxoplasma gondii can be induced but not maintained in mice lacking conventional CD4(+) T cells","volume":"70","author":"Casciotti","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.10.034_bib0170","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.4049\/jimmunol.0903450","article-title":"Virulence of Toxoplasma gondii is associated with distinct dendritic cell responses and reduced numbers of activated CD8+ T cells","volume":"185","author":"Tait","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2013.10.034_bib0175","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1365-3024.2009.01146.x","article-title":"Major role for CD8 T cells in the protection against Toxoplasma gondii following dendritic cell vaccination","volume":"31","author":"Guiton","year":"2009","journal-title":"Parasit Immunol"},{"key":"10.1016\/j.vaccine.2013.10.034_bib0180","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.4049\/jimmunol.182.2.1069","article-title":"Cell-mediated immunity to Toxoplasma gondii develops primarily by local Th1 host immune responses in the absence of parasite replication","volume":"182","author":"Gigley","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2013.10.034_bib0185","first-page":"374696","article-title":"Does Toxoplasma gondii infection affect the levels of IgE and cytokines (IL-5, IL-6, IL-10, IL-12, and TNF-alpha)?","author":"Matowicka-Karna","year":"2009","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.vaccine.2013.10.034_bib0190","doi-asserted-by":"crossref","first-page":"5935","DOI":"10.4049\/jimmunol.180.9.5935","article-title":"IL-12signalingdrivesCD8+ T cell IFN-gamma production and differentiation of KLRG+ effector subpopulations during Toxoplasma gondii infection","volume":"180","author":"Wilson","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2013.10.034_bib0195","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.4049\/jimmunol.164.5.2629","article-title":"Decreased resistance of B cell deficient mice to infection with T. gondii despite unimpaired expression of IFN-gamma. TNF-alpha and inducible nitric oxide synthase","volume":"164","author":"Kang","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2013.10.034_bib0200","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1365-3024.2007.00982.x","article-title":"Congenital and acquired toxoplasmosis: diversity and role of antibodies in different compartments of the host","volume":"29","author":"Correa","year":"2007","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.vaccine.2013.10.034_bib0205","doi-asserted-by":"crossref","first-page":"e10842","DOI":"10.1371\/journal.pone.0010842","article-title":"Absence of both IL-7 and IL-15 severely impairs the develoment of CD8 T cell response against Toxoplasma gondii","volume":"5","author":"Bhadra","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2013.10.034_bib0210","doi-asserted-by":"crossref","first-page":"e983","DOI":"10.1371\/journal.pntd.0000983","article-title":"Co-adminstration of a plasmid DNA encoding IL-15 improves long-term protection of a genetic vaccine against Trypanosomacruzi","volume":"5","author":"Eickhoff","year":"2011","journal-title":"PLoS Negl Trop Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13014102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13014102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T01:50:12Z","timestamp":1539222612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13014102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":42,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0264410X13014102"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.10.034","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DNA immunization with eukaryotic initiation factor-2\u03b1 of Toxoplasma gondii induces protective immunity against acute and chronic toxoplasmosis in mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.10.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}